Literature DB >> 27134114

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.

Akarin Hiransuthikul1, Thanapoom Rattananupong1, Jettanong Klaewsongkram2, Pawinee Rerknimitr3, Marisa Pongprutthipan4, Kiat Ruxrungtham5.   

Abstract

BACKGROUND: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but life-threatening adverse drug reaction. Several criteria have been established to aid the diagnosis. However, patients with DRESS remained underdiagnosis and undertreatment.
METHODS: Medical records of hospitalized patients at the King Chulalongkorn Memorial Hospital from January 2004-December 2014 due to DRESS were enrolled retrospectively using RegiSCAR diagnostic criteria.
RESULTS: A total of 52 patients were included. Thirty-seven patients (71.2%) were female. The four most common causative agents were phenytoin (23.1%), nevirapine (17.3%), allopurinol (15.4%), and cotrimoxazole (13.5%). The overall prevalence was 9.63 cases per 100,000 inpatients. Median onset time (IQR) was 16 (9-27) days. Allopurinol was associated with longer onset time than others (p = 0.014). CLINICAL
PRESENTATION: skin rash 100%, fever 78.8%, and lymphadenopathy 50%. The majority (84.6%) had single internal organ involvement. The most common internal organ involvement was liver (94.2%). Allopurinol was associated with higher incidence of renal involvement (p = 0.01). Up to 60% of patients had eosinophilia. Allopurinol was associated with higher eosinophilia (p = 0.003). A half of patients received systemic corticosteroids. Two mortality cases were reported (omeprazole-fulminant hepatitis and phenytoin-nosocomial infection).
CONCLUSIONS: DRESS is associated with severe morbidity and mortality. Phenytoin, nevirapine, allopurinol, and cotrimoxazole were the major causes. Allopurinol-induced DRESS had the longest onset time, and was associated with higher eosinophilia and incidence of renal involvement. Raising awareness among both health care providers and public for early detection and withdrawal of the causative agent is critical to save life and reduce morbidity.
Copyright © 2016 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adverse drug reaction; Drug hypersensitivity; Drug-induced hypersensitivity syndrome; Eosinophil; HHV-6

Mesh:

Year:  2016        PMID: 27134114     DOI: 10.1016/j.alit.2016.04.001

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  12 in total

1.  Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin.

Authors:  Muhammad Riaz; Bruce D Ragsdale; Zia Ur Rahman; Gaurav Nigam
Journal:  BMJ Case Rep       Date:  2017-08-22

Review 2.  Drug hypersensitivity in HIV infection.

Authors:  Jonny Peter; Phuti Choshi; Rannakoe J Lehloenya
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-08

3.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module.

Authors:  Anna R Wolfson; Li Zhou; Yu Li; Neelam A Phadke; Ohn A Chow; Kimberly G Blumenthal
Journal:  J Allergy Clin Immunol Pract       Date:  2018-08-31

Review 4.  Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

Authors:  Hannah Stirton; Neil H Shear; Roni P Dodiuk-Gad
Journal:  Biomedicines       Date:  2022-04-26

5.  Treatment of severe drug reactions by hemodialysis.

Authors:  Rokea A El-Azhary; Michael Z Wang; Ashley B Wentworth; LaTonya J Hickson
Journal:  Int J Dermatol       Date:  2017-11-22       Impact factor: 2.736

6.  HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients.

Authors:  Patompong Satapornpong; Jirawat Pratoomwun; Pawinee Rerknimitr; Jettanong Klaewsongkram; Nontaya Nakkam; Thanyada Rungrotmongkol; Parinya Konyoung; Niwat Saksit; Ajanee Mahakkanukrauh; Warayuwadee Amornpinyo; Usanee Khunarkornsiri; Therdpong Tempark; Kittipong Wantavornprasert; Pimonpan Jinda; Napatrupron Koomdee; Thawinee Jantararoungtong; Ticha Rerkpattanapipat; Chuang-Wei Wang; Dean Naisbitt; Wichittra Tassaneeyakul; Manasalak Ariyachaipanich; Thapana Roonghiranwat; Munir Pirmohamed; Wen-Hung Chung; Chonlaphat Sukasem
Journal:  Front Immunol       Date:  2021-05-04       Impact factor: 7.561

Review 7.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.

Authors:  Marwan H Adwan
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.686

8.  Drug Reaction with Eosinophilia and Systemic Symptoms: Retrospective Analysis of 104 Cases over One Decade.

Authors:  Li Wang; Xue-Ling Mei
Journal:  Chin Med J (Engl)       Date:  2017-04-20       Impact factor: 2.628

9.  Allopurinol-Induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome: A Cause of Acalculous Cholecystitis?

Authors:  Husnain Waseem; Faisal Inayat; Madina Abduraimova; Stephan Kamholz
Journal:  Cureus       Date:  2017-08-16

10.  Drug reaction with eosinophilia and systemic symptoms (DRESS) in children.

Authors:  Francesca Mori; Carlo Caffarelli; Silvia Caimmi; Paolo Bottau; Lucia Liotti; Fabrizio Franceschini; Fabio Cardinale; Roberto Bernardini; Giuseppe Crisafulli; Francesca Saretta; Elio Novembre
Journal:  Acta Biomed       Date:  2019-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.